Osteoarthritis of the Hip
0
Pipeline Programs
2
Companies
3
Clinical Trials
0
Approved Products
Pipeline by Development Stage
Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
0
0
0
0
Early DiscoveryClinical DevelopmentMarket
Competitive Landscape
2 companies ranked by most advanced pipeline stage
Zimmer BiometFL - Jacksonville
2 programsMetaphyseal Hip ProsthesisN/A1 trial
ReCap Total Hip ResurfacingN/A1 trial
Active Trials
StrykerCA - San Jose
1 programMedium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral StemN/A1 trial
Active Trials
NCT00951145Unknown
Trial Timeline
Clinical trial activity over time
2021
2022
2023
2024
2025
2026
Zimmer BiometMetaphyseal Hip Prosthesis
Zimmer BiometReCap Total Hip Resurfacing
Clinical Trials (3)
Total enrollment: 20 patients across 3 trials
NCT00951145StrykerMedium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
Medium and Long Term Outcome of Total Hip Arthroplasty Using Accolade TMZF Femoral Stem
N/AUnknown
The Metaphyseal Hip Prosthesis - Total Hip
Start: Oct 2012Est. completion: Dec 202320 patients
N/ACompleted
Retrospective Data Review of ReCap Total Hip Resurfacing
Start: Apr 2004Est. completion: Apr 20100
N/AWithdrawn
Phase Legend
Preclinical— Lab & animal studies
Phase 1— Safety & dosing
Phase 2— Efficacy testing
Phase 3— Large-scale trials
On Market— Approved & available
Key Insights
2 companies competing in this space
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.